ENERVIT S.P.A. PRESS RELEASE Enervit S.p.A.:
The Board of Directors approves the Draft Financial Statements and the
Consolidated Financial Statements as at 31 December 2022
Consolidated revenues of €76.3 million, up 17.8% compared to 2021, and net profit of €4.2 million, up 15.8% compared to 2021
EBITDA of €9.4 million, up 10.9% compared to 2021 and NFP up by €2.2 million compared to 2021
Milan, 16 March 2023 - The Board of Directors of Enervit S.p.A., a company active in the sports nutritional supplement and functional food market through the research, development, production and marketing of foods and supplements for those who practice sports and for the health-conscious,today approved the Draft Financial Statements of Enervit S.p.A., closed as at 31 December 2022, and approved the Consolidated Financial Statements of the Enervit Group for the year ended 31 December 2022.
Proposed distribution of a dividend of €0.13 per share (gross of legal withholdings), with payment starting from 24 May 2023, with Record date 23 May 2023 and ex- dividend date 22 May 2023.
The Shareholders' Meeting is convened for 27 April 2023
Main consolidated results as at 31 December 2022:
-
Revenues: equal to €76.3 million (compared to €64.8 million as at 31 December
2021); - EBITDA: equal to €9.4 million (compared to €8.5 million as at 31 December 2021);
- EBIT: equal to €5.5 million (compared to €4.6 million as at 31 December 2021);
- Net profit: equal to €4.2 million (compared to €3.6 million as at 31 December 2021);
- Positive net cash of €4.0 million (excluding financial payables for rent liabilities) compared to €1.8 million as at 31 December 2021;
- Group Net Financial Position: negative by €0.1 million (negative by €2.3 million as at 31 December 2021).
Main consolidated results as at 31 December 2022
As at 31 December 2022, the Enervit Group recorded revenues of €76.3 million, an increase of 17.8% compared to €64.8 million in the same period of 2021.
The result derives from a positive trend in all business areas, with Italy in particular reporting a growth of 16.7% with a percentage of revenues of 79.8%. Foreign countries, which accounted for 12.3% of total revenues, recorded an increase of 11.5% compared to 2021.
The Third Party Processing channel, with an incidence of 3.1% of total revenues, also recorded a 5.3% growth compared to 2021.
Lastly, the Direct sales channel, driven by online sales, with an incidence of 4.8% on total revenues, recorded a growth of 92.3% compared to 31 December 2021.
As at 31 December 2022, EBITDA was €9.4 million, up by 10.9% compared to 31 December 2021, when it was €8.5 million.
As at 31 December 2022 EBIT was €5.5 million, up 18.8% compared to 31 December 2021, when it was €4.6 million.
As at 31 December 2022, the Enervit Group recorded a Net Profit of €4.2 million, up 15.8% compared to 31 December 2021, when it amounted to €3.6 million.
As at 31 December 2022, the Net Financial Position was negative by €0.1 million, showing an improvement of €2.2 million compared to 31 December 2021, when it was negative by €2.3 million.
Other resolutions
The Board of Directors of Enervit S.p.A. also has:
- approved the Report on corporate governance and ownership structures, drawn up pursuant to art. 123-bis of the Consolidated Law on Finance, and the Remuneration Report, prepared pursuant to art. 123-ter of the Consolidated Law on Finance;
- proposed the distribution of a dividend of €0.13 per share (gross of legal withholdings), with payment starting from 24 May 2023, with Record date 23 May 2023 and ex-dividend date 22 May 2023;
- resolved to call the Ordinary Shareholders' Meeting for 27 April 2023, at 11.00 a.m. at Viale Achille Papa 30, Milan, with the methods envisaged by Decree Law no. 198, converted with amendments into Law no. 14 of 29 December 2022, (intervention exclusively through the designated representative) with the following agenda:
-
Approval of the Financial Statements as at 31 December 2022;
Directors' Management Report for 2022; report of the Board of
Statutory Auditors; report of the Independent Auditors. Presentation of the consolidated financial statements of the Enervit Group as at 31 December 2022. Related and consequent resolutions. - Resolutions relating to the allocation of the result for the year 2022.
- Report on the remuneration policy and fees paid:
- approval of the remuneration policy pursuant to art. 123- ter, paragraph 3-ter, of Italian Legislative Decree no. 58/1998;
- resolutions on the "second section" of the report, pursuant to art. 123-ter, paragraph 6, of Italian Legislative Decree no. 58/1998.
- Appointment of the Board of Directors (4.1) Determination of the number of members; (4.2) Determination of the term of office;
-
Approval of the Financial Statements as at 31 December 2022;
(4.3) Appointment of the members of the Board of Directors; (4.4) Appointment of the Chairperson; (4.5) Determination of the remuneration of the members of the Board of Directors.
5. Appointment of the Board of Statutory Auditors for the 2023-2025three-year period (5.1) Appointment of the members of the Board of Statutory Auditors (5.2) Appointment of the Chairperson (5.3) Determination of the remuneration of the members of the Board of Statutory Auditors.
***
The draft financial statements as at 31 December 2022, with the Management Report, the Directors' Reports for the items on the agenda of the Shareholders' Meeting, the Report of the Board of Statutory Auditors and the Report of the Independent Auditors will be made available to the public at the Company's registered office and also on the Company's website - www.enervit.com - in the "Investor Relations" section, in accordance with the law.
***
The Financial Reporting Manager of Enervit S.p.A., Mr. Giuseppe Raciti, declares - pursuant to art. 154-bis, paragraph 2 of Italian Legislative Decree 58/1998 - that the accounting information contained in this press release corresponds to the documentary results, books and accounting records.
Enervit S.p.A.
Enervit, The Positive Nutrition Company, is a company active in the sports nutritional supplement and functional food market through the research, development, production and marketing of foods and supplements for those who practice sports, for the health-conscious and those looking to stay in shape. Enervit S.p.A. promotes the culture of Positive Nutrition combined with the value of constant physical activity, and is committed to acting with respect for the environment, people and the community, to credibly contribute to a sustainable transition. The entire production process, from conception to experimentation, from fine- tuning to production, occurs in the production plants of Zelbio (CO) and Erba (CO), in order to guarantee the highest level of Quality. The Company is UNI EN ISO 9001, UNI EN ISO 14001, BRC certified. The group has 230 employees and a turnover - as at 31 December 2022 - of €76.3 million, achieved through four Sales Channels: Italy, Abroad, Third Party Processing and Direct Channel.
For further information:
Enervit S.p.A. Media Relations
Matilde Pozzi
Tel:+39 02 48563(1)
Email:m.pozzi@enervit.com-ufficiostampa@enervit.com
The economic and financial statement, and comprehensive income statement relating to the consolidated and statutory financial statements as at 31 December 2022 are attached below.
CONSOLIDATED FINANCIAL STATEMENT | ||
AS AT 31 December 2022 and 31 December 2021 | ||
(values expressed in Euro) 31 December 202231 December 2021 | ||
ASSETS | ||
Non-current assets | ||
Tangible assets | ||
Land | 207.243 | 207.243 |
Buildings | 3.160.431 | 3.392.353 |
Plant and machinery | 7.147.884 | 8.443.171 |
Industrial and commercial equipment | 537.446 | 580.409 |
Rights of Use - Tangible assets in relation to IFRS 16 | 3.861.034 | 4.211.783 |
Other assets | 195.651 | 181.262 |
Assets under construction and payments on account | 288.388 | 129.902 |
Total tangible assets | 15.398.076 | 17.146.124 |
Intangible assets | ||
Development costs | 939.648 | 980.362 |
Patent and use rights Intellectual property rights | 733.761 | 366.866 |
Concessions, licences, trademarks | 60.000 | 60.000 |
Goodwill | 5.848.557 | 5.848.557 |
Intangible assets under construction and payments on account | 223.644 | 604.265 |
Other intangible assets | 15.432 | 20.059 |
Total intangible assets | 7.821.041 | 7.880.108 |
Deferred tax assets | 410.441 | 564.150 |
Equity investments in associates/JVs | 2.177.162 | 1.994.234 |
Other long-term financial receivables | 870.912 | 343.901 |
Total financial fixed assets | 3.458.514 | 2.902.285 |
Total non-current assets | 26.677.632 | 27.928.517 |
Current assets | ||
Inventories | 9.155.454 | 6.233.744 |
Trade receivables and other short-term assets | 13.401.408 | 11.363.440 |
Trade receivables from associates | 965.976 | 701.382 |
Tax assets for current taxes | 924.245 | 700.659 |
Other short-term financial receivables | 7.105 | 913 |
Cash and cash equivalents | 16.757.494 | 18.504.912 |
Total current assets | 41.211.683 | 37.505.050 |
TOTAL ASSETS | 67.889.314 | 65.433.567 |
SHAREHOLDERS' EQUITY AND LIABILITIES | 31 December 202231 December 2021 | |
Shareholders' Equity | ||
Issued share capital | 4.628.000 | 4.628.000 |
Share premium | 6.527.962 | 6.527.962 |
Reserve for capital contributions from shareholders | 46.481 | 46.481 |
Legal reserve | 1.413.917 | 1.236.405 |
Extraordinary reserve | 9.806.536 | 8.391.807 |
Reserve for valuation of derivative instruments | 526.747 | (59.550) |
FTA reserve | 2.394.751 | 2.394.751 |
Consolidation reserves | (179.566) | (238.218) |
Profit (loss) carried forward | - | - |
Reserve for employee severance indemnity discounting | 53.203 | (47.127) |
Profit / (loss) for the year | 4.164.907 | 3.595.539 |
Total Group shareholders' equity | 29.382.938 | 26.476.049 |
Shareholders' equity pertaining to minority interests | - | - |
TOTAL SHAREHOLDERS' EQUITY | 29.382.938 | 26.476.049 |
Non-current liabilities | ||
Long-term loans | 12.799.430 | 16.782.984 |
of which liabilities for leased assets | 3.593.621 | 3.990.097 |
Long-term derivative financial instruments | - | 62.290 |
Tax liabilities for deferred taxes | 56.169 | 56.169 |
Post-employment benefits | 584.431 | 835.393 |
Other long-term liabilities | 584.253 | 700.677 |
Total non-current liabilities | 14.024.283 | 18.437.513 |
Current liabilities | ||
Trade payables and other short-term liabilities | 19.392.433 | 15.974.031 |
of which liabilities for leased assets | 465.905 | 396.411 |
Current tax liabilities | 1.502.582 | 904.042 |
Short-term loans | 3.587.078 | 3.641.932 |
Total current liabilities | 24.482.093 | 20.520.005 |
TOTAL LIABILITIES | 67.889.314 | 65.433.567 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Enervit S.p.A. published this content on 16 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 March 2023 15:54:04 UTC.
